This handout picture provided by the Sloane Kettering Cancer Center shows Dr. Michel Sadelain at Memorial Sloan Kettering Cancer Center in New York on September 25, 2017. When Michel Sadelain began his decades-long quest to genetically modify immune cells to fight cancer, his peers dismissed his ideas as absurd and even his mother grew concerned for his career. On September 14, 2023, the French and Canadian scientist was announced as a winner of the prestigious Breakthrough Prize for his pioneering work in CAR T-cell therapy, a new form of treatment that has shown exceptional efficacy against blood cancers.

https://newsinfo.inquirer.net/1831995/immunologist-wins-breakthrough-prize-for-innovative-cancer-treatment

#inquirer